Iproteos Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Iproteos General Information

Description

Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The company's therapy specializes in the research and development of third-generation drugs, such as protein-protein interactions (PPIs), enabling medical professionals to treat schizophrenia, epilepsy, pediatric cancer and other neurological disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Baldiri Reixac, 10
  • Barcelona Science Park
  • 08028 Barcelona
  • Spain
+34 934
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Baldiri Reixac, 10
  • Barcelona Science Park
  • 08028 Barcelona
  • Spain
+34 934

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Iproteos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 28-May-2020 Completed Generating Revenue
8. Early Stage VC (Series A) 15-Jul-2018 Completed Generating Revenue
7. Grant 29-May-2017 Completed Generating Revenue
6. Seed Round 25-Oct-2016 Completed Pre-Clinical Trials
5. Equity Crowdfunding 26-Sep-2016 Completed Pre-Clinical Trials
4. Seed Round 03-Jun-2015 Completed Startup
3. Equity Crowdfunding 01-Nov-2014 Completed Startup
2. Grant 01-Jan-2014 $686K $144K Completed Startup
1. Capitalization 01-Jan-2012 $144K $144K Completed Startup
To view Iproteos’s complete valuation and funding history, request access »

Iproteos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view Iproteos’s complete cap table history, request access »

Iproteos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neurological therapy designed to treat cardiovascular and central nervous systems as well as epilepsy. The
Drug Discovery
Barcelona, Spain

Barcelona, Spain
 

Richmond, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Iproteos Competitors (24)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Minoryx Venture Capital-Backed Barcelona, Spain
Sangamo Therapeutics Formerly VC-backed Richmond, CA
Forge Biologics Formerly VC-backed Grove City, OH
Ultragenyx Pharmaceutical Formerly VC-backed Novato, CA
Lumos Pharma Formerly VC-backed Austin, TX
You’re viewing 5 of 24 competitors. Get the full list »

Iproteos Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
ASCIL Biopharm Other Minority
Caixa Capital Risc Venture Capital Minority
Horizon 2020 SME Instrument Government
Kinled Holding Family Office Minority
Ministerio de Economía, Industria y Competitividad Government
To view Iproteos’s complete investors history, request access »

Iproteos FAQs

  • When was Iproteos founded?

    Iproteos was founded in 2011.

  • Where is Iproteos headquartered?

    Iproteos is headquartered in Barcelona, Spain.

  • What industry is Iproteos in?

    Iproteos’s primary industry is Drug Discovery.

  • Is Iproteos a private or public company?

    Iproteos is a Private company.

  • What is Iproteos’s current revenue?

    The current revenue for Iproteos is .

  • How much funding has Iproteos raised over time?

    Iproteos has raised $5.19M.

  • Who are Iproteos’s investors?

    ASCIL Biopharm, Caixa Capital Risc, Horizon 2020 SME Instrument, Kinled Holding, and Ministerio de Economía, Industria y Competitividad have invested in Iproteos.

  • Who are Iproteos’s competitors?

    Minoryx, Sangamo Therapeutics, Forge Biologics, Ultragenyx Pharmaceutical, and Lumos Pharma are some of the 24 competitors of Iproteos.

  • When was Iproteos acquired?

    Iproteos was acquired on 28-May-2020.

  • Who acquired Iproteos?

    Iproteos was acquired by Accure Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »